Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Crypto Market Recap: Bitcoin Rebounds After Drop Below...

June 24, 2025

Sun Summit Commences Drilling and Provides Exploration Update...

July 15, 2025

Placement Shares Issued & Drilling Approval Expected August

July 10, 2025

Lithium Universe LtdAcquisition of Solar Panel Recycling Technology

June 18, 2025

Empire Metals Limited Announces Warrant Exercise

June 13, 2025

FPX Nickel Announces Share-Based Compensation Grant

July 12, 2025

Top 9 Nickel-producing Countries

June 5, 2025

Group Eleven Announces C$5M Bought Deal Private Placement

July 22, 2025

Crypto Market Recap: Trump Media Files for Third...

July 14, 2025

Canadian Wildfires Force Mining Sector to Retreat as...

June 3, 2025